SARS-CoV-2 spike protein ligand binding BioAssay™ kit allows rapid quantification of COVID-19 neutralizing antibodies in serum and plasma by measuring reduction in the binding of viral spike protein with its receptor ACE2. This assay allows rapid analysis of convalescent plasma, antibody-based therapeutics, vaccine leads, and immune response to the virus. This serological platform was designed as a tool to begin understanding the correlation between neutralizing antibody level and protective immunity in recovered SARS-CoV-2.
- Rapid: 1.5 hours total time
- Versatile: No cells or virus used, therefore suitable for USL1 lab
- Open Platform: 96 well plate reader